Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

Immunogenicity, Effectiveness, and Safety of Trivalent Inactivated Influenza Split Vaccine in Patients with Inflammatory Joint Diseases Receiving Modern Antirheumatic Therapy

According to the currently available data from large cohort studies, patients with immuno-inflammatory rheumatic diseases (IIRDs) are at increased risk of infectious complications, including influenza, compared to the general population. Vaccinations are a critical component of their care. However,...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	M. M. Baranova, N. V. Muravyeva, B. S. Belov, M. E. Diatroptov, D. V. Bukhanova
Μορφή:	Άρθρο
Γλώσσα:	Russian
Έκδοση:	LLC "Publishing House OKI" 2024-06-01
Σειρά:	Антибиотики и Химиотерапия
Θέματα:	influenza rheumatoid arthritis ankylosing spondylitis psoriatic arthritis vaccination efficacy immunogenicity safety
Διαθέσιμο Online:	https://www.antibiotics-chemotherapy.ru/jour/article/view/1129

Παρόμοια τεκμήρια

Immunogenicity, efficacy and safety of the three-valent inactivated influenza split vaccine in patients with ankylosing spondylitis and psoriatic arthritis
ανά: M. M. Baranova, κ.ά.
Έκδοση: (2024-06-01)

Efficacy, safety and immunogenicity of a trivalent inactivated split influenza vaccine in patients with rheumatic diseases
ανά: D. V. Bukhanova, κ.ά.
Έκδοση: (2018-07-01)

Do individuals with inflammatory arthritis receive minimally adequate treatment for incident depression and anxiety: A population-based study
ανά: Alyssa Howren, κ.ά.
Έκδοση: (2025-01-01)

Gait characteristics associated with the foot and ankle in inflammatory arthritis: a systematic review and meta‐analysis
ανά: Matthew Carroll, κ.ά.
Έκδοση: (2015-01-01)

Persistence and costs with subcutaneous TNF-alpha inhibitors in immune-mediated rheumatic disease stratified by treatment line
ανά: Svedbom A, κ.ά.
Έκδοση: (2017-01-01)

Rheumatoid arthritis and spondyloarthritis prevalence in four European countries - a comparative study
ανά: Zlatković-Švenda Mirjana, κ.ά.
Έκδοση: (2022-01-01)

Association Between Nursing Support Levels and Effectiveness of Golimumab in the Management of Patients with Rheumatologic Diseases
ανά: Hermine Leroi, κ.ά.
Έκδοση: (2020-05-01)

Comorbidities in inflammatory joint and spine diseases in XXI century
ανά: I Z Gaydukova, κ.ά.
Έκδοση: (2018-12-01)

Persistence to subcutaneous biological agents in Hungarian patients treated for inflammatory arthritis
ανά: Takacs P, κ.ά.
Έκδοση: (2019-01-01)

Biologics and cardiovascular events in inflammatory arthritis: a prospective national cohort study
ανά: Joshua L. Lee, κ.ά.
Έκδοση: (2018-08-01)

The frequency and structure of comorbid infections in patients with spondyloarthritis (preliminary own data)
ανά: M. M. Baranova, κ.ά.
Έκδοση: (2021-03-01)

Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
ανά: M. Rossini, κ.ά.
Έκδοση: (2015-03-01)

Hypogonadism in men with inflammatory joint diseases: Frequency and clinical characteristics
ανά: Taras S. Panevin, κ.ά.
Έκδοση: (2024-06-01)

The data project: a shared approach between stakeholders of the healthcare system in definition of a therapeutic algorithm for inflammatory arthritis
ανά: I. Pantano, κ.ά.
Έκδοση: (2023-03-01)

Significance of Interleukin (IL)-4 and IL-13 in Inflammatory Arthritis
ανά: Milena Iwaszko, κ.ά.
Έκδοση: (2021-11-01)

Ankylosing spondylitis and psoriatic arthritis: clinical and economic consequences of the use of etanercept
ανά: Viola Sacchi, κ.ά.
Έκδοση: (2010-06-01)

Circulating miRNA Correlates with Lipid Profile and Disease Activity in Psoriatic Arthritis, Rheumatoid Arthritis, and Ankylosing Spondylitis Patients
ανά: Krzysztof Bonek, κ.ά.
Έκδοση: (2022-04-01)

Impact of tumor necrosis factor inhibitors and methotrexate on diabetes mellitus among patients with inflammatory arthritis
ανά: Santhi Mantravadi, κ.ά.
Έκδοση: (2020-09-01)

Use of antidepressants and benzodiazepine-related hypnotics before and after initiation of TNF-α inhibitors or non-biological systemic treatment in patients with rheumatoid arthritis, psoriatic arthritis or ankylosing spondylitis
ανά: Philip Brenner, κ.ά.
Έκδοση: (2020-02-01)

Evaluation of the possibility of axial psoriatic arthritis patients meet classification criteria for axial spondyloarthritis and ankylosing spondylitis
ανά: E. E. Gubar, κ.ά.
Έκδοση: (2023-08-01)

Nod-like receptors in inflammatory arthritis
ανά: Sahib Singh Madahar, κ.ά.
Έκδοση: (2024-02-01)

Inflammatory arthritis and eye diseases: a Mendelian randomization study
ανά: Xinlin Nie, κ.ά.
Έκδοση: (2023-10-01)

Pooled safety results across phase 3 randomized trials of intravenous golimumab in rheumatoid arthritis, psoriatic arthritis, and ankylosing spondylitis
ανά: M. Elaine Husni, κ.ά.
Έκδοση: (2022-03-01)

A Prospective Study to Evaluate the Impact of Golimumab Therapy on Work Productivity and Activity, and Quality of Life in Patients With Rheumatoid Arthritis, Psoriasis Arthritis and Axial Spondyloarthritis in a Real Life Setting in AUSTRIA. The GO-ACTIVE Study
ανά: Christian Dejaco, κ.ά.
Έκδοση: (2022-06-01)

SAFETY AND EFFECTIVENESS OF TRI VALENT INACTIVATED SPLIT VIRION INFLUENZA VACCINE IN PATIENTS WITH RHEUMATOID DISORD ERS
ανά: D. V. Bukhanova, κ.ά.
Έκδοση: (2018-07-01)

The association of relapsing polychondritis and spondylarthritis – three case reports
ανά: Eleonora Alina Dragomir-Lica, κ.ά.
Έκδοση: (2023-09-01)

Characteristics of patients with psoriatic arthritis in Korea: focusing on axial involvement
ανά: Hanna Park, κ.ά.
Έκδοση: (2024-01-01)

Treatment persistence of subcutaneous TNF inhibitors among Australian patients with immune-mediated rheumatic disease (IMRD)
ανά: Acar M, κ.ά.
Έκδοση: (2018-11-01)

The interchangeability of original tumor necrosis factor- α inhibitors and biosimilars in rheumatology: experience in replacing original infliximab with Flammagis for ankylosing spondylitis
ανά: Yu. V. Muravyev, κ.ά.
Έκδοση: (2020-05-01)

Adherence to biological therapies in patients with chronic inflammatory arthropathies
ανά: Noemí Martínez-López de Castro, κ.ά.
Έκδοση: (2019-07-01)

Unraveling immune cell heterogeneity in autoimmune arthritis: insights from single-cell RNA sequencing
ανά: Sotaro Nakajima, κ.ά.
Έκδοση: (2024-10-01)

Management of tuberculosis risk, screening and preventive therapy in patients with chronic autoimmune arthritis undergoing biotechnological and targeted immunosuppressive agents
ανά: Andrea Picchianti-Diamanti, κ.ά.
Έκδοση: (2025-02-01)

The troubling liaison between cancer and metabolic syndrome in chronic inflammatory rheumatic diseases
ανά: Giovanni Cioffi, κ.ά.
Έκδοση: (2021-03-01)

Diagnosis of spondyloarthritis: should we need new criteria?
ανά: I. Z. Gaidukova, κ.ά.
Έκδοση: (2015-03-01)

Prevalence of spondyloarthritis and its subtypes - are they really comparable?
ανά: Zlatković-Švenda Mirjana I., κ.ά.
Έκδοση: (2019-01-01)

Significance of asymptomatic hyperuricemia in ankylosing spondylitis
ανά: R. M. Balabanova, κ.ά.
Έκδοση: (2021-06-01)

Inflammatory back pain in psoriatic arthritis is significantly more responsive to corticosteroids compared to back pain in ankylosing spondylitis: a prospective, open-labelled, controlled pilot study
ανά: Muhammad Haroon, κ.ά.
Έκδοση: (2018-04-01)

Newly diagnosed seropositive rheumatoid arthritis in a 52-year-old man superimposed on long-standing ankylosing spondylitis during secukinumab treatment
ανά: Jaroslaw Nowakowski, κ.ά.
Έκδοση: (2023-10-01)

Coexistence of rheumatoid arthritis and ankylosing spondylitis
ανά: Tacjana Anna Barczyńska, κ.ά.
Έκδοση: (2015-12-01)

Features of medical and social expertise in ankylosing spondylitis and psoriatic arthritis
ανά: T. V. Dubinina, κ.ά.
Έκδοση: (2023-02-01)